Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich, Proteome Sciences Lock in Distribution Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Proteome Sciences said today that it has struck a non-exclusive license agreement with Sigma-Aldrich enabling Sigma to continue selling the ProteoPrep kits in Europe, Japan, and Australia.

The agreement gives Proteome a signing fee and royalties on all eleven of its ProteoPrep kits sold in the three regions. It also covers all future products sold under the ProteoPrep trademark that contain chemicals and reagents for the disruption of cells, tissues, or other biological material and the extraction of biological molecules like proteins, lipids, and carbohydrates.

The trademark also covers methods and processes relating to assays for diagnosing diseases and chemical markers that disrupt cells, tissues, or other materials for determining drug targets and proteins and peptides, the company said.

Further financial terms of the agreement were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more